NeuroPace (NPCE) Return on Equity [ROE] (2021 - 2026)
NeuroPace (NPCE) reported Return on Equity [ROE] of -144.52% for Q2 2026, down 25.58 percentage points from -118.94% a year earlier and down 16.21 percentage points from the prior quarter.
NeuroPace (NPCE) Return on Equity [ROE] (2021 - 2026) Analysis & Trends
For FY2025, NeuroPace posted Return on Equity [ROE] of -155.15%, up 36.33 percentage points from FY2024.
- Return on Equity [ROE] has a three-year change of -68.81 percentage points (FY2022 to FY2025).
- By year, Return on Equity [ROE] came in at -191.47% in FY2024 (-73.70 pp), -117.77% in FY2023 (-31.43 pp) and -86.34% in FY2022.
- The Q2 2026 figure ranks as the lowest quarterly Return on Equity [ROE] since Q1 2025.
- Year over year, Return on Equity [ROE] gained in five of the last eight quarters, with an average year-over-year change of +36.96 percentage points.
- The high point for year-over-year Return on Equity [ROE] in five years was Q4 2025 (a gain of 193.42 percentage points); the low point was Q4 2024 (a drop of 131.39 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at -128.31% (Q1 2026), -114.33% (Q4 2025) and -125.94% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 249.71 Bn | 228.86 Bn | 4.88 Bn | 13.36% |
| 2 | Abbott Laboratories | 171.00 Bn | 142.08 Bn | 7.27 Bn | 10.39% |
| 3 | Danaher | 155.79 Bn | 139.61 Bn | 3.61 Bn | 7.56% |
| 4 | Intuitive Surgical | 143.91 Bn | 123.46 Bn | 1.96 Bn | 17.60% |
| 5 | Medtronic | 110.42 Bn | 76.29 Bn | 6.34 Bn | 10.44% |
| 6 | Stryker | 105.71 Bn | 91.82 Bn | 4.50 Bn | -3.90% |
| 7 | Boston Scientific | 63.26 Bn | 58.27 Bn | 3.85 Bn | 14.31% |
| 8 | Edwards Lifesciences | 49.80 Bn | 33.91 Bn | 1.35 Bn | 9.53% |
| 9 | Becton Dickinson | 48.78 Bn | 45.93 Bn | 2.32 Bn | 3.88% |
| 10 | NeuroPace | 471.73 Mn | 244.98 Mn | 18.91 Mn | -144.52% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -144.52% |
| Mar 31, 2026 | -128.31% |
| Dec 31, 2025 | -114.33% |
| Sep 30, 2025 | -125.94% |
| Jun 30, 2025 | -118.94% |
| Mar 31, 2025 | -154.74% |
| Dec 31, 2024 | -307.75% |
| Sep 30, 2024 | -291.72% |
| Jun 30, 2024 | -251.36% |
| Mar 31, 2024 | -183.22% |
| Dec 31, 2023 | -176.36% |
| Sep 30, 2023 | -197.80% |
| Jun 30, 2023 | -170.32% |
| Mar 31, 2023 | -144.04% |
| Dec 31, 2022 | -119.57% |
| Sep 30, 2022 | -96.43% |
| Jun 30, 2022 | -73.77% |
| Mar 31, 2022 | -53.49% |
| Dec 31, 2021 | -39.56% |
| Sep 30, 2021 | -29.20% |
NeuroPace Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=NPCE&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "NPCE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=NPCE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();